Novo Nordisk (Ondo Tokenized Stock) (NVOON)
CryptoScore Pro Gesamtscore : 65/100 (berechnet am 2026-10-29)
Novo Nordisk (Ondo Tokenized Stock), ticker NVOON, is a tokenized representation of shares of the Danish pharmaceutical company Novo Nordisk, issued on the Ethereum blockchain. It belongs to the real world assets (RWA) sector and, more precisely, to the tokenized stocks category published by Ondo Finance. Its purpose is to give crypto-native holders on-chain exposure to the price performance of a listed equity without custody through a traditional brokerage account. The token is classified under Tokenized Assets, Tokenized Stocks, Real World Assets (RWA) and Ondo Tokenized Assets, and it is also listed in the Binance Smart Chain and Solana ecosystems, which reflects its multi-chain deployment. The token contract is deployed on Ethereum at address 0x28151f5888833d3d767c4d6945a0ee50d1b193e3, was created on 23 July 2025, is verified on the block explorer and is implemented as a proxy contract, which allows the issuer to upgrade the logic without changing the address. Equivalent contracts are referenced on Binance Smart Chain at 0x08a513779f46ffb7a34f16094a94016d010128a8 and on Solana under the identifier GeV7S8vjP8qdYZpdGv2Xi6e7MUMCk8NAAp2z7g5ondo. The tokens are designed to track…
Scores nach Säule
| Technologie | 70/100 |
|---|---|
| Tokenomics | 90/100 |
| Team | 46/100 |
| Adoption | 41/100 |
| Liquidität | 55/100 |
| Compliance | 75/100 |
Marktdaten
| Preis | 40,07 $ |
|---|---|
| Marktkapitalisierung | 2,11 Mio. $ |
| 24-h-Volumen | 1,07 Mio. $ |
| Rang nach Marktkapitalisierung | #2348 |
| 24-h-Änderung | +2,05 % |
| 7-Tage-Änderung | +0,76 % |
| Blockchain | Ethereum |
| Sektor | RWA |
Analyse
NVOON bietet den Zugang zu Novo-Nordisk-Aktien ohne Broker. Dieser Token repräsentiert eine Pharmaaktie auf Ethereum über einen Proxy-Vertrag, der technische Aktualisierungen ohne Änderung der Adresse ermöglicht. Der Token ermöglicht eine On-Chain-Exponierung gegenüber der Kursentwicklung einer börsennotierten Aktie.